MedIPX.com retweeted
According to the latest preliminary statistics from China's National Medical Products Administration (NMPA), the total value of outbound licensing deals for innovative Chinese drugs exceeded $60 billion during the first three months of 2026. @MedIPXcom @tymedorg @APEC2026 @hkumed
As of February 15, there have been 39 license-out transactions for innovative drugs in China, with initial payments of approximately US$2.953 billion and a total amount exceeding US$49 billion.
@tymedorg @MedIPXcom
Business Development (BD) Transactions of Chinese Innovative Drugs Abroad from 2021 to 2026 (To Date)
@tymedorg @MedIPXcom
By 2025, the total value of my country's innovative drug licensing transactions abroad will exceed US$130 billion.
#MedIPX #Drugs #Licenseout #NewCo @tymedorg @MedIPXcom @HKUniversity @EliLillyandCo @APEC2026 @FDA_Drug_Info @US_FDA
How about tokenizing medical intellectual property?
#MedIP #Tokenization #RWA #Financing
@MedIPXcom @OndoFinance
HKSAR Government's Commerce and Economic Development Bureau, the IP Department, and the HKMA jointly launched the IP Financing Sandbox, marking a significant milestone for Hong Kong in promoting IP financing, further developing the IP trading ecosystem, and fostering innovation.
MedIPX.com retweeted
The APEC Seminar and Informal Senior Officials’ Meeting (ISOM) opened Thursday in Shenzhen, marking the first major event as China prepares to host the APEC Leaders’ Meeting in 2026.
亚太经合组织研讨会暨非正式高官会议(ISOM)于周四在深圳开幕,这是中国为筹备2026年亚太经合组织领导人会议而举办的首个重大活动。
#APEC #APEC2026 #Shenzhen #China
@APEC @APECBiz @APEC_Centre_AU @APEC2026








